Study finds erythropoietin gene polymorphism increases retinopathy risk in type 2 diabetes, suggesting its role in complications.
Our results demonstrate that in T2DM patients the EPO rs1617460 polymorphism is associated with significantly increased risk of developing DR. This finding can provide a new insight into the role of EPO gene in the pathophysiology of microvascular complications of diabetes.
No takes yet. Share an insight, caveat, or question.
Szeliga-Król et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: